My Innovo

Health & Beauty

My Innovo sells FDA-cleared women’s health devices focused on pelvic-floor strengthening, period pain relief and postpartum recovery. Flagship SKUs include the Innovo shorts for stress-urinary-incontinence therapy (≈$299–$399) and the recently launched Period Pain Relief Band (≈$129); all products sit in the mid-to-premium price tier. Distribution is DTC through myinnovo.com and select Amazon marketplaces; no brick-and-mortar retail. The brand’s core IP is a built-in multi-path NMES (neuromuscular electrical stimulation) system that delivers 180 precise pulses per session, removing the need for vaginal probes. Clinical data cited on the site shows 93 % of users leak-free after 12 weeks, a claim that underpins its medical-grade positioning. Innovo’s wearable shorts have become a go-to non-surgical option recommended by UK NHS pelvic-health physiotherapists. Primary buyers are women 30-55 who have given birth or are experiencing light bladder leakage and want a home-use, non-invasive fix. Messaging stresses “take back control” and discreet 30-minute sessions that fit around work or childcare, appealing to convenience-driven, health-curious consumers who value evidence over gimmicks. Competitors include low-cost Kegel apps, probe-based stimulators and disposable incontinence products; Innovo differentiates with a garment-style, probe-free design and published clinical outcomes. By positioning itself as a medical device rather than a lifestyle gadget, the brand commands higher prices while still undercutting surgical solutions, carving out a niche between commodity kegel tools and expensive clinical therapy.

Medical-grade shorts that fix what surgery can't, without the surgery